January 08, 2021
22 min listen
Save
COVID-19 and the Rheumatologist: The Good, the Bad and the Ugly
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
We end the year with Leonard Calabrese, DO, giving us a summary of what we’ve learned about COVID-19 from the perspective of a rheumatologist.
Brought to you by GSK. Considering a treatment change for patients with active SLE? Learn about a treatment option for your patients at treatfortodayandtomorrow.com.
- Intro :10
- Dr. Calabrese introduction :24
- In this episode :43
- Nobody has complete control of the literature on COVID-19 1:39
- What was ugly about COVID-19? 2:16
- What was bad about COVID-19? 4:05
- What good came from the COVID-19 pandemic? 7:07
Brought to you by GSK. Consider the long-term impact of disease activity flares and corticosteroid use on patients with active SLE. Learn more now at treatfortodayandtomorrow.com.
- The good things continued 10:20
- JAK inhibitors 11:30
- The best outcomes: Vaccines 14:15
- Pertinent questions for the rheumatology community 16:45
- Recap 20:12
- Conclusion 21:41
We’d love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum
Published by:
Sources/Disclosures
Collapse
Disclosures:
Calabrese reports no relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
